Bicalutamide-impurities | Pharmaffiliates

bicalutamide

Bicalutamide was patented in 1982 and approved for medical use in 1995. It is sold under the brand name Casodex among others, is an antiandrogen medication that is primarily used to treat prostate cancer.. Reference standards of Bicalutamide API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below

stdClass Object
(
    [pname] => Bicalutamide-d4 Sulfide
    [catalogue_number] => PA STI 012750
    [category_ids] => ,79,80,78,70,82,88,98,
    [chemical_name] => 
    [weight] => 402.40
    [form] => C18H10D4F4N2O2S
    [cas] => NA
    [pslug] => bicalutamide-d4-sulfide-pasti012750
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA STI 012750

Bicalutamide-d4 Sulfide


  • Catalogue No.:PA STI 012750

  • CAS :

    NA

  • Molecular Formula : C18H10D4F4N2O2S

  • Molecular Weight : 402.40